help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pash, J. M.
Right arrow Articles by Canalis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pash, J. M.
Right arrow Articles by Canalis, E.

Endocrinology, Vol 136, 33-38, Copyright © 1995 by Endocrine Society


ARTICLES

Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells

JM Pash, AM Delany, ML Adamo, CT Roberts Jr, D LeRoith and E Canalis
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105.

Insulin-like growth factor I (IGF-I) is a widely expressed abundant autocrine and paracrine factor that regulates the proliferation and differentiation of a variety of cell types. Prostaglandin E2 (PGE2) is a potent stimulator of IGF-I synthesis in bone. We examined the regulation of IGF-I synthesis by PGE2 in osteoblast-enriched (Ob) cells from fetal rat calvaria. PGE2 treatment of Ob cells at 1 microM for 2 h resulted in a 5-fold increase in heterogeneous nuclear RNA levels, as measured by a reverse transcriptase-polymerase chain reaction assay, suggesting an increase in IGF-I gene transcription. RNase protection analysis was used to map the transcriptional start sites in the IGF-I gene that are used in Ob cells. Consistent with other extrahepatic tissues, initiation of transcription occurs primarily at three sites within the 5'-regions of exon 1 of the IGF-I gene. PGE2 treatment did not alter start site usage. The regions upstream of these transcriptional start sites were analyzed by transiently transfecting Ob cells with putative rat IGF-I promoter sequences ligated to a luciferase reporter gene. Constructs containing 1.4 kilobases of the 5'- regions regions of exons 1 and 2 had significant promoter activity. PGE2 treatment of transfected Ob cells increased luciferase activity 5- fold when a 1.4-kilobase exon 1 promoter fragment was tested. This increase in luciferase activity was time and dose dependent. Smaller regions of the exon 1 promoter sequence gave higher basal activity and were less responsive to PGE2. We conclude that regions involved in IGF- I regulation by PGE2 are contained within the IGF-I promoter.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Granado, A. I Martin, M{a} A. Villanua, and A. Lopez-Calderon
Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1656 - E1665.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. W. Wynes and D. W. H. Riches
Transcription of macrophage IGF-I exon 1 is positively regulated by the 5'-untranslated region and negatively regulated by the 5'-flanking region
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1089 - L1098.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. KJAeR
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
Physiol Rev, April 1, 2004; 84(2): 649 - 698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. E. McCall, D. L. Allen, F. Haddad, and K. M. Baldwin
Transcriptional regulation of IGF-I expression in skeletal muscle
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C831 - C839.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. M. Delany, D. Durant, and E. Canalis
Glucocorticoid Suppression of IGF I Transcription in Osteoblasts
Mol. Endocrinol., October 1, 2001; 15(10): 1781 - 1789.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. E. Johnson, R. Vogel, S. J. Rutledge, G. Rodan, and A. Schmidt
Thiazolidinedione Effects on Glucocorticoid Receptor-Mediated Gene Transcription and Differentiation in Osteoblastic Cells
Endocrinology, July 1, 1999; 140(7): 3245 - 3254.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
M. E. Martinez, D. Heddens, D. L. Earnest, C. L. Bogert, D. Roe, J. Einspahr, J. R. Marshall, and D. S. Alberts
Physical Activity, Body Mass Index, and Prostaglandin E2 Levels in Rectal Mucosa
J Natl Cancer Inst, June 2, 1999; 91(11): 950 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Umayahara, J. Billiard, C. Ji, M. Centrella, T. L. McCarthy, and P. Rotwein
CCAAT/Enhancer-binding Protein delta  Is a Critical Regulator of Insulin-like Growth Factor-I Gene Transcription in Osteoblasts
J. Biol. Chem., April 9, 1999; 274(15): 10609 - 10617.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg
Growth Hormone and Bone
Endocr. Rev., February 1, 1998; 19(1): 55 - 79.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Umayahara, C. Ji, M. Centrella, P. Rotwein, and T. L. McCarthy
CCAAT/Enhancer-binding Protein delta  Activates Insulin-like Growth Factor-I Gene Transcription in Osteoblasts. IDENTIFICATION OF A NOVEL CYCLIC AMP SIGNALING PATHWAY IN BONE
J. Biol. Chem., December 12, 1997; 272(50): 31793 - 31800.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Franchimont, V. Gangji, D. Durant, and E. Canalis
Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts
Endocrinology, December 1, 1997; 138(12): 5248 - 5255.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Wang, Y. Yang, and M. L. Adamo
Characterization of the Rat Insulin-Like Growth Factor I Gene Promoters and Identification of a Minimal Exon 2 Promoter
Endocrinology, April 1, 1997; 138(4): 1528 - 1536.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Thomas, Y. Umayahara, H. Shu, M. Centrella, P. Rotwein, and T. L. McCarthy
Identification of the cAMP Response Element That Controls Transcriptional Activation of the Insulin-like Growth Factor-I Gene by Prostaglandin E2 in Osteoblasts
J. Biol. Chem., September 6, 1996; 271(36): 21835 - 21841.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Gabbitas, J. M. Pash, A. M. Delany, and E. Canalis
Cortisol Inhibits the Synthesis of Insulin-like Growth Factor-binding Protein-5 in Bone Cell Cultures by Transcriptional Mechanisms
J. Biol. Chem., April 12, 1996; 271(15): 9033 - 9038.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Delany, J. J. Jeffrey, S. Rydziel, and E. Canalis
Cortisol Increases Interstitial Collagenase Expression in Osteoblasts by Post-transcriptional Mechanisms
J. Biol. Chem., November 3, 1995; 270(44): 26607 - 26612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Billiard, Y. Umayahara, K. Wiren, M. Centrella, T. L. McCarthy, and P. Rotwein
Regulated Nuclear-Cytoplasmic Localization of CCAAT/ Enhancer-binding Protein delta in Osteoblasts
J. Biol. Chem., April 27, 2001; 276(18): 15354 - 15361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society